India's Supreme Court Dismisses Novartis AG Drug Patent Case
- OurStudio
- Apr 1, 2013
- 1 min read
India's highest court has dismissed Swiss drug maker Novartis AG's petition seeking patent protection for a cancer drug, a serious blow to Western pharmaceutical firms which are increasingly focusing on India to drive sales.
In a landmark judgement, the Supreme Court said on Monday that the drug Glivec failed to qualify for a patent according to Indian law.
Коментарі